SURGICAL SCIENCE UK LIMITED
Get an alert when SURGICAL SCIENCE UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2026-08-03 (in 3mo)
Last made up 2025-07-20
Watchouts
None on the register
Cash
£1M
+116.4% vs 2024
Net assets
-£16M
-34.9% vs 2024
Employees
33
-10.8% vs 2024
Profit before tax
-£4M
-293.1% vs 2024
Name history
Renamed 1 time since incorporation
- SURGICAL SCIENCE UK LIMITED 2025-05-28 → present
- MEDAPHOR LIMITED 2004-07-12 → 2025-05-28
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Turnover | £7,039,000 | £4,473,000 | |
| Operating profit | £2,154,000 | -£4,117,000 | |
| Profit before tax | £2,142,000 | -£4,137,000 | |
| Net profit | £2,262,000 | -£4,181,000 | |
| Cash | £483,000 | £1,045,000 | |
| Total assets less current liabilities | -£11,530,000 | -£15,556,000 | |
| Net assets | -£11,530,000 | -£15,556,000 | |
| Equity | -£11,530,000 | -£15,556,000 | |
| Average employees | 37 | 33 | |
| Wages | £2,392,000 | £3,068,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | 30.6% | -92.0% | |
| Net margin | 32.1% | -93.5% | |
| Return on capital employed | -18.7% | 26.5% | |
| Gearing (liabilities / total assets) | 216.0% | 289.6% | |
| Current ratio | 0.29x | 0.20x | |
| Interest cover | 179.50x | -205.85x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- S&W Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors believe existing cash reserves, expected cash flows from operating activities as well as parental support if required, are sufficient to meet the Company's obligations as they fall due for at least the next twelve months from the date of approval of these financial statements. The Directors have therefore concluded that it is appropriate to prepare the Company financial statements on a going concern basis. The financial statements do not include any adjustments that would result if the Company was unable to continue as a going concern.”
Significant events
- “On 28 May 2025 the company was renamed from Medaphor Limited to Surgical Science UK Limited.”
- “On 18 February 2025, 100% of the share capital of its parent company Surgical Science UK Holdings Ltd was acquired by Surgical Science Sweden AB.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BURNS, Thomas Richard | Secretary | 2026-04-16 | — | — |
| AHLBERG, Anna Sofia | Director | 2025-02-18 | Oct 1970 | Swedish |
| ENGLUND, Tom Erik Ilmar | Director | 2025-02-18 | Jul 1976 | Swedish |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COX, Eryl Vanessa | Secretary | 2008-09-25 | 2011-06-28 |
| GILL, Max Joseph | Secretary | 2004-07-12 | 2006-11-17 |
| GILL, Peter Emrys | Secretary | 2006-11-17 | 2008-09-25 |
| HARRISON, Irene Lesley | Nominee Secretary | 2004-07-12 | 2004-07-12 |
| JENNINGS, Wilson Whitehead | Secretary | 2014-05-01 | 2019-12-31 |
| JONES, Helen Mary Kinsey | Secretary | 2020-01-01 | 2026-04-16 |
| AMSO, Nazar Najib | Director | 2004-12-08 | 2022-06-22 |
| AVIS, Nicholas John | Director | 2007-04-30 | 2023-04-30 |
| BAYNES, David Graham | Director | 2010-06-16 | 2022-06-22 |
| COX, Eryl Vanessa | Director | 2007-04-30 | 2010-01-13 |
| FICKLING, Roger Howard | Director | 2004-12-09 | 2009-05-31 |
| GALL, Stuart Arthur | Director | 2009-12-16 | 2025-02-18 |
| GILL, Max Joseph | Director | 2004-07-12 | 2004-12-08 |
| GILL, Peter Emrys | Director | 2004-07-12 | 2008-09-17 |
| JENNINGS, Wilson Whitehead | Director | 2014-05-01 | 2019-12-31 |
| JONES, Helen Mary Kinsey | Director | 2020-01-01 | 2026-04-16 |
| PIGLIUCCI, Riccardo | Director | 2012-11-01 | 2023-04-30 |
| SLEEP, Nicholas James | Director | 2012-08-01 | 2024-10-01 |
| WHITTAKER, Ian George | Director | 2019-01-01 | 2023-12-31 |
| BUSINESS INFORMATION RESEARCH & REPORTING LIMITED | Corporate Nominee Director | 2004-07-12 | 2004-07-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Surgical Science Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-16 | Active |
| Intelligent Ultrasound Group Plc | Legal person | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 143 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-05-28 CERTNM Certificate change of name company PDF
- 2024-12-18 RESOLUTIONS Resolution
- 2024-12-18 MA Memorandum articles
- 2024-12-16 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-10 | AA | accounts | Accounts with accounts type full | |
| 2026-04-16 | TM02 | officers | Termination secretary company with name termination date | |
| 2026-04-16 | AP03 | officers | Appoint person secretary company with name date | |
| 2026-04-16 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-11-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-09-29 | AA | accounts | Accounts with accounts type full | |
| 2025-08-12 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-08-12 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-12 | CH01 | officers | Change person director company with change date | |
| 2025-05-28 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-05-14 | MR05 | mortgage | Mortgage charge whole cease with charge number | |
| 2025-05-14 | MR05 | mortgage | Mortgage charge whole cease and release with charge number | |
| 2025-04-29 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-04-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-18 | RESOLUTIONS | resolution | Resolution | |
| 2024-12-18 | MA | incorporation | Memorandum articles | |
| 2024-12-16 | CC04 | change-of-constitution | Statement of companys objects |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 13
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31
-
Turnover
-36.5%
£7,039,000 £4,473,000
-
Cash
+116.4%
£483,000 £1,045,000
-
Net assets
-34.9%
-£11,530,000 -£15,556,000
-
Employees
-10.8%
37 33
-
Operating profit
-291.1%
£2,154,000 -£4,117,000
-
Profit before tax
-293.1%
£2,142,000 -£4,137,000
-
Wages
+28.3%
£2,392,000 £3,068,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers